Correlation Between Sarepta Therapeutics and Monopar Therapeutics
Can any of the company-specific risk be diversified away by investing in both Sarepta Therapeutics and Monopar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sarepta Therapeutics and Monopar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sarepta Therapeutics and Monopar Therapeutics, you can compare the effects of market volatilities on Sarepta Therapeutics and Monopar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sarepta Therapeutics with a short position of Monopar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sarepta Therapeutics and Monopar Therapeutics.
Diversification Opportunities for Sarepta Therapeutics and Monopar Therapeutics
-0.07 | Correlation Coefficient |
Good diversification
The 3 months correlation between Sarepta and Monopar is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Sarepta Therapeutics and Monopar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monopar Therapeutics and Sarepta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sarepta Therapeutics are associated (or correlated) with Monopar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monopar Therapeutics has no effect on the direction of Sarepta Therapeutics i.e., Sarepta Therapeutics and Monopar Therapeutics go up and down completely randomly.
Pair Corralation between Sarepta Therapeutics and Monopar Therapeutics
Given the investment horizon of 90 days Sarepta Therapeutics is expected to generate 16.2 times less return on investment than Monopar Therapeutics. But when comparing it to its historical volatility, Sarepta Therapeutics is 12.22 times less risky than Monopar Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Monopar Therapeutics is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 145.00 in Monopar Therapeutics on September 14, 2024 and sell it today you would earn a total of 2,393 from holding Monopar Therapeutics or generate 1650.34% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sarepta Therapeutics vs. Monopar Therapeutics
Performance |
| Timeline |
| Sarepta Therapeutics |
| Monopar Therapeutics |
Sarepta Therapeutics and Monopar Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sarepta Therapeutics and Monopar Therapeutics
The main advantage of trading using opposite Sarepta Therapeutics and Monopar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sarepta Therapeutics position performs unexpectedly, Monopar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monopar Therapeutics will offset losses from the drop in Monopar Therapeutics' long position.| Sarepta Therapeutics vs. Puma Biotechnology | Sarepta Therapeutics vs. Iovance Biotherapeutics | Sarepta Therapeutics vs. Day One Biopharmaceuticals | Sarepta Therapeutics vs. Inozyme Pharma |
| Monopar Therapeutics vs. Puma Biotechnology | Monopar Therapeutics vs. Iovance Biotherapeutics | Monopar Therapeutics vs. Day One Biopharmaceuticals | Monopar Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |